Are those quoted success figures for drugs that are already approved translating into new indications or new unapproved drugs? I know the answer just thought you might want to correct your post so you can't be accused of trying to mislead. So, there is risk and time involved in bring a drug to market for a new indication. Who knew? Amazing insight. The issue Clinuvel shareholders have is the chance of success is not priced in and it is frustrating compared to our peers.
- Forums
- ASX - By Stock
- CUV
- Ann: Media release - First stroke patient with afamelanotide
Ann: Media release - First stroke patient with afamelanotide, page-16
-
- There are more pages in this discussion • 19 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CUV (ASX) to my watchlist
|
|||||
Last
$14.74 |
Change
0.190(1.31%) |
Mkt cap ! $738.1M |
Open | High | Low | Value | Volume |
$14.60 | $14.79 | $14.32 | $881.1K | 60.57K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 87 | $14.67 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$14.79 | 2000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 87 | 14.670 |
2 | 288 | 14.640 |
1 | 288 | 14.610 |
2 | 388 | 14.580 |
1 | 288 | 14.560 |
Price($) | Vol. | No. |
---|---|---|
14.790 | 2000 | 1 |
14.820 | 288 | 1 |
14.840 | 288 | 1 |
14.870 | 288 | 1 |
14.900 | 288 | 1 |
Last trade - 16.10pm 10/09/2024 (20 minute delay) ? |
Featured News
CUV (ASX) Chart |